Norway reclassifies Covid-19 disease. It is no more dangerous than the common flu

The Norwegian Institute of Public Health (FHI) classifies Covid-19 disease as respiratory, as dangerous as the common flu. On the other hand, it clarifies that the pandemic is not over, but has entered a new phase – Covid-19 is now the equivalent of a common respiratory disease, such as the flu or a respiratory infection – due to several factors: the mutations that they suffered from SARS-Cov-2, which makes it less dangerous, the natural and vaccine-induced immunity that Norwegian society has achieved.

Although the virus continues to circulate, it does not cause an increase in the number of hospitalizations, which means that SARS-Cov-2 no longer puts pressure on the Norwegian medical system. FHI now evaluates coronavirus as similar to other respiratory viruses, such as those that cause the common cold or seasonal flu.

In studies conducted by FHI, it was found that both partially and fully vaccinated people with Covid-19 have a low risk of hospitalization, but that the same applies to healthy people who do not belong to risk groups.

According to the latest FHI statistics, 67 new patients were hospitalized with Covid-19 as the main cause during week 37, which is a decrease from 95 cases in the previous week. Of the new cases at week 37, only 9 patients needed intensive care, a decrease from 22 the previous week.

In Norway, 90% of citizens over the age of 18 received the first dose and 83% received the second dose – therefore they are considered fully vaccinated.

For the most important news of the day, broadcast in real time and presented equidistantly, LIKE our Facebook page!

read more  Sedesa asks residents of the capital to respect the vaccination schedule for minors

Follows Mediafax on Instagram to see spectacular pictures and stories from around the world!

The content of the website is intended exclusively for your personal information and use. It is prohibited republishing the content of this site in the absence of an agreement from MEDIAFAX. To obtain this agreement, please contact us at [email protected]

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Never miss any important news. Subscribe to our newsletter.